For instance, CD24-/CD44+ breast CSCs are mesenchymal-like, primarily quiescent, and localized at the tumor-invasive front, whereas ALDH+ breast CSCs are epithelial-like and proliferative, and more centrally located [56]. The gene discussed is CD24; the disease is neoplasm.